We are on the launch pad!Up 25% today on 4.7 million shares traded. Once we break .06 we will head to .10 swiftly. It’s very little overhead resistance after .06. The chart is a beauty coming off the bottom. The market looks to be anticipating news. Once the trials start and we reopen our treatment clinic we will have a steady news flow and the share price will act accordingly.
Universal Ibogaine is a life science company, with a mission to transform addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorder and ultimately to utilize that protocol globally through planned future licensing agreements. Universal Ibogaine is concurrently developing a state-of-the-art holistic addiction treatment protocol at its Kelburn Recovery Centre that, when paired with the planned ibogaine detox protocol, is intended to revolutionize the way addiction is treated and drastically improve the lives of individuals and families affected by addiction.